See more : RTG Mining Inc. (RTG.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Odonate Therapeutics, Inc. (ODT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Odonate Therapeutics, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Alliance Sports Group, L.P. (BOLL) Income Statement Analysis – Financial Results
- RESAAS Services Inc. (RSS.V) Income Statement Analysis – Financial Results
- Lotus Ventures Inc. (LTTSF) Income Statement Analysis – Financial Results
- Foseco India Limited (FOSECOIND.BO) Income Statement Analysis – Financial Results
- Computer Services, Inc. (CSVI) Income Statement Analysis – Financial Results
Odonate Therapeutics, Inc. (ODT)
About Odonate Therapeutics, Inc.
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.
Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 117.04M | 104.03M | 79.95M | 27.90M | 2.62M | 0.00 |
General & Administrative | 10.39M | 10.90M | 10.82M | 4.84M | 463.00K | 158.00K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 10.39M | 10.90M | 10.82M | 4.84M | 463.00K | 158.00K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -316.00K |
Operating Expenses | 127.43M | 114.93M | 90.76M | 32.74M | 3.09M | -158.00K |
Cost & Expenses | 127.43M | 114.93M | 90.76M | 32.74M | 3.09M | 158.00K |
Interest Income | 0.00 | 3.11M | 1.80M | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 445.00K | 381.00K | 350.00K | 20.00K | 22.82K | 0.00 |
EBITDA | -125.91M | -111.44M | -88.61M | -32.72M | -3.09M | -158.00K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -127.43M | -114.93M | -90.76M | -32.74M | -3.09M | -158.00K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 1.08M | 3.11M | 1.80M | 0.00 | 0.00 | 0.00 |
Income Before Tax | -126.35M | -111.83M | -88.96M | -32.74M | -3.09M | -158.00K |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 1.08M | 3.11M | 1.80M | 0.00 | 0.00 | 0.00 |
Net Income | -126.35M | -111.83M | -88.96M | -32.74M | -3.09M | -158.00K |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -3.85 | -4.05 | -3.64 | -2.31 | -0.11 | -0.01 |
EPS Diluted | -3.85 | -4.05 | -3.64 | -2.31 | -0.11 | -0.01 |
Weighted Avg Shares Out | 32.82M | 27.63M | 24.46M | 14.17M | 26.89M | 26.89M |
Weighted Avg Shares Out (Dil) | 32.82M | 27.63M | 24.46M | 14.17M | 26.89M | 26.89M |
The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
Odonate Therapeutics to Present at the Jefferies Virtual Healthcare Conference
Odonate Therapeutics (NASDAQ:ODT) Stock Rating Upgraded by Zacks Investment Research
Geode Capital Management LLC Has $5.45 Million Position in Odonate Therapeutics Inc (NASDAQ:ODT)
Odonate Therapeutics Inc (NASDAQ:ODT) Shares Sold by Bank of America Corp DE
Zacks Investment Research Downgrades Odonate Therapeutics (NASDAQ:ODT) to Hold
Odonate Therapeutics Inc (NASDAQ:ODT) Shares Purchased by Bank of New York Mellon Corp
Odonate Therapeutics Inc (NASDAQ:ODT) Given Average Rating of "Hold" by Brokerages
Odonate Therapeutics Inc (NASDAQ:ODT) Sees Significant Decline in Short Interest
Goldman Sachs Group Inc. Reduces Stock Position in Odonate Therapeutics Inc (NASDAQ:ODT)
Source: https://incomestatements.info
Category: Stock Reports